Received Jul 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y015108 | — |
No symptoms reported; HCP called to report a temperature excursion for VARIVAX and PROQUAD. HCP reported that VARIVAX and PROQUAD were administered to multiple patients on multiple dates after being improperly stored. This case pertains to one patient who received imprope; This spontaneous report was received from other health professional and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 19-Jun-2025, the patient was vaccinated with an improperly stored Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), Injection (lot #Y015108 which has been verified to be a valid number, expiration date reported and validated 06-Sep-2026) 0.5 mL. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) as a prophylaxis (incorrect product storage). The vaccine administered was stored at temperature of 6.3 degrees Fahrenheit (F) for a time frame of 16 minutes. There was no previous temperature excursion. No symptoms reported. This is one of several reports received from the same reporter.
Sterile diluent